Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-11-09
1996-08-13
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514300, 546123, 546156, A61K 3147, C07D21520
Patent
active
055456421
ABSTRACT:
The invention relates to novel derivatives of 1-(2-fluorocyclopropyl)-quinolonecarboxylic acid and 1-(2-fluorocyclopropyl)-naphthyridonecarboxylic acid which are substituted in the 7 position by a 2,3,4,5,6,7-hexahydro-1H-pyrrolo[3,4-c]pyridin-2-yl or 1,2,3,4,5,6-hexahydropyrrolo[3,4-c]pyrrol-2-yl residue, to their salts, to a process for their preparation and to antibacterial agents containing these derivatives.
REFERENCES:
patent: 5091384 (1992-02-01), Kim et al.
patent: 5274167 (1993-12-01), Lange et al.
patent: 5312823 (1994-05-01), Petersen et al.
Atarashi, S. Imamura M. Kimura Y. Yoshida A. Hayakawa I. J. Med Chem., vol. 36, pp. 3444-3448 (1993).
B ohm Stefan
Bremm Klaus D.
Endermann Rainer
Grosser Rolf
Metzger Karl G.
Bayer Aktiengesellschaft
Huang Evelyn
Ivy C. Warren
LandOfFree
Derivatives of 1-(2-fluorocyclopropyl)-quinolonecarboxylic acid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Derivatives of 1-(2-fluorocyclopropyl)-quinolonecarboxylic acid , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of 1-(2-fluorocyclopropyl)-quinolonecarboxylic acid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1048086